Sign up
Pharma Capital
EPIC: ACRX
Market: NASDAQ
52-week High/Low: $5.05 / $2.00
Sector: Pharma & Biotech
Market Cap: $263.84M
Website: www.acelrx.com

AcelRx Pharmaceuticals is a development-stage specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of acute pain. The Company's lead product candidate, Zalviso, is intended for the management of moderate-to-severe acute pain in hospitalized adult patients.

AcelRx Pharmaceuticals

www.acelrx.com

Interactive graph

col 3
col 4
col 5
col 6
View full ACRX profile View Profile
View All

Market Reports Including ACRX

VIEW ALL

Executive video interviews

VIEW ALL VIDEOS

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.